VYNE Therapeutics
VYNE28.5600.00% ( 0.000 )
VYNE Therapeutics (VYNE)
VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 28.560
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 44.995
- Volume Ratio
- 0.00
- Turnover Ratio
- --
News
- Global Report · 2 days ago, 04:13 AM
The Market's Unmapped Edges: What a Basket of Fringe Stocks Reveals About 2026
- businessinsider · Jul 25 at 12:59 AM
VYNE Therapeutics trading halted, news pending
- benzinga_article · Jul 24 at 03:35 AM
Why SAP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
- PUBT · Jul 23 at 03:50 PM
Vyne Therapeutics set for 1-for-50 reverse stock split on July 24
- StockTitan · Jul 23 at 07:26 AM
VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience | VYNE Stock News
- rttnews · Jul 21 at 07:35 AM
VYNE Therapeutics Sets 1-for-50 Reverse Stock Split Ahead Of Yarrow Merger
